About half of people with ataxia-telangiectasia have vitamin D deficiency, according to a 2026 meta-analysis of four studies. Gram Research analysis found that 50.8% of A-T patients had vitamin D levels below 20 ng/mL, with an additional 26.8% experiencing severe deficiency below 10 ng/mL. These findings suggest doctors should routinely screen A-T patients for vitamin D deficiency and consider supplementation to support bone health and immune function.
A new analysis of published research found that vitamin D deficiency is very common in people with ataxia-telangiectasia (A-T), a rare genetic disorder affecting the nervous system and immune function. According to Gram Research analysis, about 50% of A-T patients studied had dangerously low vitamin D levels. The research combined data from four studies to get a clearer picture of this problem. Doctors should routinely check vitamin D levels in A-T patients and consider treatment, as vitamin D plays important roles in bone health, immune function, and overall wellness. The findings highlight the need for more research on whether vitamin D supplements could help people with this condition.
Key Statistics
A 2026 meta-analysis of four studies found that 50.8% of people with ataxia-telangiectasia had vitamin D deficiency, defined as levels below 20 ng/mL.
According to research reviewed by Gram, 26.8% of ataxia-telangiectasia patients in published studies had severe vitamin D deficiency with levels below 10 ng/mL.
The pooled average vitamin D level in ataxia-telangiectasia patients was 19.65 ng/mL, just below the deficiency threshold of 20 ng/mL, according to the 2026 meta-analysis.
Only 38.1% of ataxia-telangiectasia patients in the analyzed studies had adequate vitamin D levels, while 21.9% had insufficiency.
The Quick Take
- What they studied: How common is vitamin D deficiency in people with ataxia-telangiectasia, a rare genetic disorder that affects movement and the immune system?
- Who participated: The analysis combined data from four published studies that measured vitamin D levels in patients with ataxia-telangiectasia. The exact total number of patients wasn’t specified, but the studies included people of various ages with this rare condition.
- Key finding: About half (50.8%) of people with ataxia-telangiectasia had vitamin D deficiency, defined as levels below 20 ng/mL. Additionally, about 27% had severe deficiency with levels below 10 ng/mL.
- What it means for you: If you or a family member has ataxia-telangiectasia, doctors should check vitamin D levels regularly. Low vitamin D can affect bone strength and immune function, so treatment may be important. However, more research is needed to determine the best way to treat this deficiency in A-T patients.
The Research Details
Researchers conducted a systematic review, which means they searched medical databases for all published studies measuring vitamin D levels in people with ataxia-telangiectasia. They found four studies that met their criteria and combined the results using a statistical method called meta-analysis. This approach allows researchers to pool data from multiple smaller studies to get a clearer overall picture than any single study could provide.
The researchers looked at vitamin D levels using a standard blood test that measures 25-hydroxyvitamin D, or 25(OH)D. They defined deficiency as levels below 20 ng/mL (nanograms per milliliter), severe deficiency as below 10 ng/mL, and insufficiency as levels that weren’t quite deficient but weren’t ideal either. They also calculated the average vitamin D level across all studies.
To ensure the studies they included were reliable, the researchers assessed their quality using a standard checklist called the Newcastle-Ottawa Scale. This helps readers understand whether the findings are trustworthy.
This research approach is important because ataxia-telangiectasia is a rare condition, so individual studies often include only small numbers of patients. By combining multiple studies, researchers can see patterns that might not be obvious in any single study. This gives doctors a better understanding of how common vitamin D deficiency really is in A-T patients, which can help guide clinical care decisions.
The analysis included only four studies, which is a relatively small number. The researchers found good consistency in their results for deficiency rates (meaning the studies agreed with each other), but more variation for some other measurements. The studies were observational, meaning they measured vitamin D levels but didn’t test whether giving vitamin D supplements would help. Larger, well-designed intervention studies are needed to determine the best treatment approach.
What the Results Show
The main finding was that vitamin D deficiency is very common in ataxia-telangiectasia patients. Approximately 50.8% of patients in the published studies had vitamin D levels below 20 ng/mL, which is considered deficient. This means that about one in two A-T patients has low vitamin D.
Beyond simple deficiency, the research also examined more severe cases. About 26.8% of patients had severe vitamin D deficiency with levels below 10 ng/mL. Additionally, 21.9% had insufficiency, meaning their levels were low but not quite deficient. Only 38.1% of patients had adequate vitamin D levels.
When researchers calculated the average vitamin D level across all studies, they found it was 19.65 ng/mL, which is right at the threshold of deficiency. This low average confirms that vitamin D problems are widespread in this population.
The analysis revealed that vitamin D problems in A-T patients are not just a minor issue but a significant health concern affecting the majority of this population. The consistency of results across different studies (low statistical variation) suggests that vitamin D deficiency is a genuine feature of ataxia-telangiectasia rather than a random finding. The researchers noted that A-T is a multisystem disorder, meaning it affects many parts of the body, and nutritional problems like vitamin D deficiency appear to be part of the overall disease pattern.
While previous research had described vitamin D deficiency in individual A-T patients and small groups, this is the first analysis to pool data and quantify exactly how common the problem is. The findings confirm what doctors suspected: vitamin D deficiency is not rare in A-T but rather a frequent occurrence that deserves routine clinical attention. The research supports the idea that vitamin D screening should become standard practice for A-T patients.
The analysis included only four published studies, which limits how confident we can be in the results. The studies were observational rather than experimental, meaning they measured vitamin D levels but didn’t test whether supplements would help. The exact number of total patients studied wasn’t clearly reported. The studies may have used slightly different methods to measure vitamin D, which could affect comparisons. Most importantly, this research shows that vitamin D deficiency is common but doesn’t prove that treating it will improve health outcomes in A-T patients. More research is needed to determine whether vitamin D supplements should be routinely given and what dose would be most helpful.
The Bottom Line
Doctors should routinely check vitamin D levels in patients with ataxia-telangiectasia using a simple blood test. If deficiency is found, vitamin D supplementation should be considered, though the optimal dose and form haven’t been established through clinical trials. Patients should also be counseled about vitamin D sources including sun exposure and dietary sources like fortified milk and fatty fish. These recommendations are based on the high prevalence of deficiency found in this analysis, though stronger evidence from intervention studies would be valuable.
This research is most relevant to people with ataxia-telangiectasia and their doctors. Family members and genetic counselors should also be aware, as A-T is an inherited condition. Healthcare providers who care for A-T patients should consider adding vitamin D screening to their routine care. People with other rare genetic disorders affecting the nervous system might also benefit from vitamin D screening, though this study specifically addresses A-T.
If vitamin D deficiency is identified and supplementation is started, it typically takes several weeks to months to see improvements in blood levels. Benefits to bone health and immune function may take longer to become apparent. Regular monitoring with blood tests every 3-6 months would help determine if supplementation is working effectively.
Frequently Asked Questions
What is ataxia-telangiectasia and why does it cause vitamin D deficiency?
Ataxia-telangiectasia is a rare genetic disorder affecting the nervous system and immune function. It causes nutritional and endocrine problems, including vitamin D deficiency, though the exact mechanisms aren’t fully understood. About half of A-T patients have low vitamin D levels.
How common is vitamin D deficiency in people with ataxia-telangiectasia?
Very common. A 2026 analysis of published studies found that approximately 50.8% of ataxia-telangiectasia patients had vitamin D deficiency, with another 26.8% experiencing severe deficiency. This means vitamin D problems affect most A-T patients.
Should people with ataxia-telangiectasia take vitamin D supplements?
Doctors should check vitamin D levels in A-T patients and consider supplementation if deficiency is found. However, the optimal dose and form haven’t been established through clinical trials. Treatment decisions should be made with a healthcare provider familiar with A-T.
What are the health risks of low vitamin D in ataxia-telangiectasia?
Low vitamin D can weaken bones, increase fracture risk, and impair immune function. In A-T patients, these effects could be particularly concerning given the condition already affects the immune system. More research is needed to understand the specific consequences in A-T.
How is vitamin D deficiency diagnosed and monitored?
A simple blood test measuring 25-hydroxyvitamin D (25(OH)D) levels diagnoses deficiency. Levels below 20 ng/mL indicate deficiency. Doctors should monitor A-T patients regularly, checking levels every few months if supplementation is started to ensure treatment is working.
Want to Apply This Research?
- Track quarterly vitamin D blood test results (measured in ng/mL) to monitor whether supplementation is raising levels toward the adequate range of 30 ng/mL or higher.
- If you have ataxia-telangiectasia, set a reminder to take a daily vitamin D supplement as prescribed by your doctor, and log your supplement intake in the app to ensure consistency.
- Create a long-term tracking dashboard showing vitamin D test results over time, with target ranges clearly marked. Share results with your healthcare provider during regular check-ins to adjust supplementation if needed.
This article summarizes research findings about vitamin D deficiency in ataxia-telangiectasia but should not replace professional medical advice. If you or a family member has ataxia-telangiectasia, consult with your healthcare provider about vitamin D screening and appropriate treatment. The findings presented are based on observational studies and do not prove that vitamin D supplementation will improve health outcomes. Individual treatment decisions should be made in consultation with a doctor familiar with your specific medical situation.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.